CSIC have found that coated iron oxide (IONPs) and iron oxyhydroxide nanoparticles (IOHNPs) can be used in the treatment and prevention of viral infections caused by Coronaviridae, especially those caused by respiratory syndrome-related coronaviruses selected from the species “Severe acute respiratory syndrome-related coronavirus” (such as SARS-CoV and SARS-CoV-2) and “Middle East respiratory syndrome-related coronavirus” (MERS-CoV). These coated nanoparticles can provide protection against coronaviruses and represent a new treatment for COVID-19 disease.
Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement.
Material de descarga